4.100
+2,50%
2026-10-19
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +322.4% | +87.9% | 2 / 3 | -7.9% | +0.77 pp | +7.93 pp | +2.3% | 0.29 | 16.46 | 57,4 | −7,9% | 5,8 | +322,4% | 16.46 | 8.78 | +87,5% |
| Pts | 12 | 12 | 8 | 0 | 8 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 4.100 (close price on 2026-10-19)EPS (TTM): 249,0
Financial charts
1.Revenue & growth
VND bn57,4Q2/26
1.Revenue & growth
VND bn57,4Q2/26
2.Profit & growth
VND bn5,83Q2/26
3.Profit mix (Penman)
VND bn6,90Q2/26
4.Margins & cost structure
%12.8%Q2/26
5.Returns & cash cycle
% · days0.9%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn359Q2/26
8.Funding & debt health
VND bn · times359Q2/26
9.Revenue backlog
VND bn6,22Q2/26
10.Valuation
times · %16,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %243Q2/26
Adjusted EPS growth, latest quarter
322%
Average adjusted EPS growth, 3 quarters
84.8%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26